U.S. Stock News

Rapport Therapeutics (RAPP) is back in focus after new efficacy data for its lead candidate RAP-219, progress toward Phase 3 planning, and weaker trial results from a competing epilepsy therapy. See our latest analysis for Rapport Therapeutics. Despite the latest data and analyst attention, Rapport Therapeutics’ share price has slipped 8.6% over the past week and 5.1% over the past month. However, its 90 day share price return of 18.2% and one year total shareholder return of about 2x suggest...

KBR, Inc. recently announced that its Mission Technology Solutions business has been awarded a 20-year, US$8.00 billion-ceiling Antarctic Science and Engineering Support Contract by the U.S. National Science Foundation, covering operations, logistics, maintenance, and technical services for all U.S. Antarctic research stations and related field sites. This long-duration, single-award IDIQ contract underscores KBR’s role in complex government science programs and adds a substantial,...

Beam Therapeutics (BEAM) is back in focus after new clinical data for its BEAM-302 program showed sustained protective protein levels. This supports an accelerated FDA review path and helps to reset investor attention on the stock. See our latest analysis for Beam Therapeutics. The fresh BEAM-302 data arrives after a sharp pullback, with a 1-day share price return of down 10.47% and a 7-day share price return of down 10.72%. However, the 1-year total shareholder return of 58.28% contrasts...

In late May 2026, Cheniere Energy Partners, L.P. awarded Bechtel a US$4.69 billion engineering, procurement and construction contract for Train 7 and related infrastructure at its Sabine Pass LNG expansion project in Louisiana. This new contract extends a long-standing collaboration between the two companies at Sabine Pass and signals a substantial multi-decade commitment to expanding US LNG export capacity. We’ll examine how this large Sabine Pass Train 7 contract shapes Cheniere Energy...

Pagaya Technologies recently completed a US$600,000,000 structured notes offering at 100% of principal and reported first-quarter 2026 earnings per share of US$0.73, well ahead of forecasts. Alongside this, CEO Gal Krubiner increased his shareholding and the company appointed Terry O’Neil as Chief Commercial Officer, highlighting management’s commitment to scaling partnerships and products. We’ll now examine how the strong earnings surprise and Terry O’Neil’s appointment as Chief...

Dover recently reported strong first-quarter 2026 results, highlighting solid revenue growth, robust order momentum, and a book-to-bill ratio above one across all five operating segments. Management’s decision to maintain full-year 2026 revenue and adjusted EPS guidance, backed by capacity and productivity investments, underscores growing confidence in the company’s demand outlook. We’ll now examine how Dover’s broad-based order strength and reaffirmed 2026 guidance may influence the earlier...

In recent days, Edgewise Therapeutics announced inducement stock option grants to four new non-executive employees under its 2024 Inducement Equity Incentive Plan, while several Wall Street firms reiterated positive views on the company. Beyond the routine equity awards, the clustering of upbeat analyst opinions highlights how external research coverage can shape investor perception of Edgewise Therapeutics’ longer-term prospects. Next, we’ll examine how this wave of bullish analyst...

In recent months, American International Group (AIG) has experienced leadership changes with CEO Peter Zaffino departing and Eric Anderson taking over, while also reshaping its portfolio by selling its Corebridge Financial stake and acquiring Everest Group Ltd.'s Colombia subsidiary to build out its Latin American insurance footprint. At the same time, AIG’s dividend profile has attracted attention, with a yield above industry and S&P 500 levels and a multi‑year pattern of dividend growth...

In late May 2026, Ropes & Gray and Arkwright Consulting each announced they had selected Intapp’s DealCloud platform, with Ropes & Gray also adopting the new Celeste agentic AI to connect growth, compliance, and profitability workflows. These wins highlight growing real‑world adoption of Intapp’s cloud and AI stack across legal and consulting firms, directly tying its technology roadmap to mission‑critical client workflows. Next, we’ll examine how Celeste’s launch as an agentic AI layer for...

What recent trading tells you about UL Solutions (ULS) Recent trading in UL Solutions (ULS) has drawn attention after the stock closed at US$96.81, with short term returns down over the past week and month but higher over the past 3 months. For investors, that mix of softer near term performance and stronger past 3 months returns raises questions about how to weigh the company’s fundamentals. These include its testing, inspection, certification and software operations across Industrial,...

Recent commentary on Immunovant’s IMVT-1402 program highlighted high response rates in a completed Phase 2 rheumatoid arthritis trial, including in patients who had already received multiple advanced therapies. This focus on difficult-to-treat patients has pushed IMVT-1402 to the center of Immunovant’s story, raising questions about how such response rates could shape expectations for its broader autoimmune pipeline. We’ll now look at how the strong IMVT-1402 Phase 2 responses in difficult...

In late May 2026, Palomar Holdings reported first-quarter operating income and revenue that surpassed analyst expectations, added former Houlihan Lokey CEO Scott Beiser to its board and key committees, and authorized a US$200.00 million share repurchase program running through May 2028. This combination of stronger-than-expected operating performance, enhanced governance expertise, and a sizable buyback authorization offers fresh insight into how management is balancing growth ambitions with...

Conference spotlight and recent valuation signals GATX (GATX) is drawing fresh investor attention after Thomas A. Ellman, its executive vice president and chief financial officer, was scheduled to present at the Wells Fargo 16th Industrials & Materials Conference. That spotlight has coincided with renewed interest in how the stock screens on respected valuation tools, as well as how those metrics compare with concerns that have been raised about the company’s lower financial strength...

In late May 2026, Echodyne announced a partnership with Axon Enterprise to integrate its MESA radar into Axon’s public safety drone ecosystem, enhancing low-altitude airspace awareness for both authorized and unauthorized drone activity worldwide. At the same time, Motorola Solutions’ US$1.5 billion acquisition of counter-drone specialist D-Fend Solutions intensifies head-to-head competition with Axon in drones, AI-enabled public safety technologies, and integrated hardware-software...

In late May 2026, Peabody Energy Corporation issued US$225 million of 0.50% senior unsecured convertible notes due June 1, 2031, priced at 100% and sold under Rule 144A. This bond sale coincided with U.S. government use of the Defense Production Act and significant federal funding to support coal infrastructure, directly tying Peabody’s new financing to policy-driven coal demand. We’ll now examine how this government-backed coal support and Peabody’s new convertible notes may influence the...

La-Z-Boy stock in focus La-Z-Boy (LZB) is drawing investor attention after recent share price moves, with the stock roughly flat over the past month but higher over the past 3 months, prompting a closer look at its fundamentals. See our latest analysis for La-Z-Boy. At a share price of US$36.33, La-Z-Boy has seen a modest gain over the past 3 months. The share price return since the start of the year is slightly down and the 1 year total shareholder return is also lower, suggesting momentum...

Moody’s recently upgraded Tenet Healthcare Corporation’s Corporate Family Rating to Ba2 from Ba3 and revised the outlook to stable, citing sustained deleveraging supported by strong EBITDA and substantial debt reduction over the past two years. This upgrade highlights the growing importance of Tenet’s ambulatory care expansion and disciplined financial policies in shaping the company’s credit profile and operational flexibility. With this credit upgrade underscoring Tenet’s focus on...

Recently, Timken received renewed investor attention after Oppenheimer highlighted management’s revised 80/20-led operating model as a key driver of operating performance. This focus on an 80/20 framework, which emphasizes higher-value customers and products, has become a central pillar of how investors assess Timken’s efficiency and profitability potential. Next, we’ll explore how this 80/20-led operating model emphasis interacts with Timken’s existing investment narrative and expectations...

AutoZone (AZO) is back in focus after its Q3 2026 report showed higher sales, net income and earnings per share versus a year ago, along with fresh supply chain investments and new mega hub openings. See our latest analysis for AutoZone. AutoZone's share price has been under pressure, with a 30 day share price return down 10.86% and a 90 day share price return down 15.15%. However, recent Q3 results, capital spending and buybacks have kept longer term total shareholder returns positive over 3...

Stanley Black & Decker (SWK) is reshaping its business after an aggressive acquisition phase by selling non core assets, tightening operations, and maintaining a 50 year dividend streak that keeps income focused investors watching the stock. See our latest analysis for Stanley Black & Decker. Recent price action has been mixed, with the share price down 3.19% over the past month but up 3.78% over 90 days and a 22.75% one year total shareholder return. This combination hints that restructuring...

AT&T (T) is back in focus as investors react to fresh concerns about satellite broadband competition, a downgrade from Oppenheimer, and growing operational pressure from widespread copper thefts across its network. See our latest analysis for AT&T. The recent downgrade and concerns about satellite broadband have coincided with a clear loss of momentum, with AT&T’s share price return down 17.36% over the past 90 days and its 1 year total shareholder return down 15.45%, despite longer term...

In recent days, Citizens Financial Group benefited from a regional bank rally as investors reacted to wider net interest margins driven by easing deposit costs and still-elevated loan yields. At the same time, concerns around an assessment that the bank appears significantly overvalued and recent insider share sales have added a layer of caution to this improving sentiment. With regional banks gaining on wider net interest margins, we'll now explore what this means for Citizens Financial...

Recent analysis has highlighted that Baxter International is trading well below various estimates of its intrinsic value and its own historical valuation multiples, prompting fresh investor attention in early June 2026. The combination of a comparatively low price-to-earnings ratio and an absence of recent insider transactions is feeding a perception that the shares may offer value without obvious internal red flags. Next, we will examine how this perceived undervaluation interacts with...

Toll Brothers (TOL) stock is back in focus after the company reported better-than-expected earnings, raised full-year guidance, and continued rolling out new high-end communities aimed at affluent buyers across several US markets. See our latest analysis for Toll Brothers. At a share price of US$137.91, Toll Brothers has cooled off in the short term, with the 90 day share price return down 6.27%, even as the 1 year total shareholder return sits at 29.48% and the 5 year total shareholder...